Harvard Business Review

MAY 2, 2011

As multinational corporations pursue opportunities in emerging markets, they're bound to stumble if they overlook the developed economies, and vice versa. Without operating in the former, they won't be able to attain economies of scale; sans the latter, they're unlikely to continue developing state-of-the-art technologies.

Globalization 13

Globalization Marketing Venture Capitalist Biotechnology 13

Harvard Business Review

FEBRUARY 17, 2011

Venture capitalists are increasingly interested in emerging markets, and in working with local funds based in those markets (despite the fact that reverse innovation in venture capital seems counterintuitive). In contrast, emerging-market VCs such as Nadathur Holdings (established in 2000 by N.S.

Marketing 15

Marketing Venture Capitalist Biotechnology IPO 15

Harvard Business Review

MARCH 2, 2012

As global companies focus their strategies on developed and emerging markets, they require substantial cadres of leaders capable of operating effectively anywhere in the world. American companies and academic institutions possess unique competitive advantages in developing these global leaders.

Competitive Advantage 12

Competitive Advantage Globalization Development Intellectual Capital 12

The Horizons Tracker

NOVEMBER 29, 2023

However, the research also highlights the significance of diverse educational, industrial, and organizational backgrounds among managers and board members in fostering innovation in research and development (R&D), thereby generating both economic and social value.

Diversity 94

Diversity Innovation Biotechnology Short-term 94

Harvard Business Review

MAY 7, 2018

She was on the legal compliance team at a fast-growing biotechnology company. Her role was to work with marketing to ensure that promotional campaigns and materials were in line with government guidelines. Karen had always been invited to key marketing meetings, but she noticed that more and more meetings were happening without her.

Restructuring 13

Restructuring How To Compliance Biotechnology 13

Harvard Business Review

OCTOBER 26, 2011

Despite these gloomy headlines, three developments in the sector give us hope that the revolution in clean energy production is far from dead: 1. Their behavior displays promising parallels to the early days of the biotechnology industry.

Energy 10

Energy Finance IPO Biotechnology 10

Harvard Business Review

NOVEMBER 15, 2016

In contrast, New England has increasingly become a hub for ventures in life sciences; the first three-quarters of 2016 saw almost 60% of VC investments in New England go to ventures in biotechnology and medical devices. Witness the case of Uber, which has a market valuation exceeding $60 billion and is still a privately held company.

Biotechnology 8

Biotechnology Drucker Software Entrepreneur 8

Harvard Business Review

JUNE 21, 2013

Given the forecasts of uncertain global economic growth, we might expect companies to hold off from hiring new employees and to limit whatever international hiring they do to emerging markets. We also find that companies in developed areas plan to hire in other developed regions (e.g., Asia into North America).

Telecommunications 9

Telecommunications Health Care Talent Management Biotechnology 9

Harvard Business Review

MARCH 11, 2014

Start-up companies tend to cluster in industries favored by venture capitalists (like biotechnology or information technology) or ones where there are relatively low barriers to entry (like restaurants). In these markets if existing companies don’t rise to the innovation challenge, no one will.

Innovation 8

Innovation Venture Capitalist Company Supply Chain 8

Harvard Business Review

FEBRUARY 22, 2013

Your company has just developed an amazing new product. Years of development, energy, and, of course, money have gone into it. Cephalon's IPO was in 1991, part of the second wave of biotechnology companies to sell shares to the public. Baldino moved aggressively to bring Provigil to market. What do you do next?

Productivity 8

Productivity Products Biotechnology IPO 8

Harvard Business Review

MAY 10, 2016

After all, if acquisitions pay off they can provide a transformational antidote to a slowing core market and declining margins. Gillette dominated the men’s shaving market with its Mach series of razors. For example, Gilead grew from a tiny startup developing H.I.V.

Strategy 8

Strategy Company Biotechnology Franchising 8

Harvard Business Review

OCTOBER 1, 2014

With an eye towards broadening and amplifying this conversation, we have developed a Scale Up Declaration , which we offer as a rallying point for what the entrepreneurship discussion should focus on, and what it should aim to accomplish. But wait a minute – is starting more new businesses always a good thing?

Entrepreneur 11

Entrepreneur Biotechnology Real Estate Innovation 11

Harvard Business Review

AUGUST 17, 2015

There was a spike in the 2000s when Venezuela began to provide petroleum at deeply discounted market prices, and that peaked just before the 2008-09 financial crisis. It is probably the best, most well-trained workforce at the cheapest labor-market price that any international investor could find anywhere in the world.

Biotechnology 8

Biotechnology Tourism Human Capital Pharmaceuticals 8

Harvard Business Review

SEPTEMBER 14, 2011

Chirotech specializes in biocatalysis and chemocatalysis, two important subspecialties of biotechnology and chemistry that help develop key biological and chemical intermediates needed for the efficient production of medicines. Besides Dr Reddy's, several leading Indian firms are pioneering polycentric innovation: Tata Motors.

Globalization 9

Globalization Innovation Decentralization Chemicals 9

Strategy Driven

NOVEMBER 18, 2019

This increased the need for care items for the elderly and there are plenty of gaps in the market for the healthcare sector. There have also been great leaps forward in biotechnology and even people without investment experience in the industry can find a niche sector to become involved in. Financial sector.

Health Care 67

Health Care Biotechnology Energy Insurance 67

Harvard Business Review

JUNE 3, 2013

Many wonder why an academy company like P&G, historically known for developing talent, did not, or was not able to, promote a successor from within its ranks. Is the problem that P&G produces outstanding specialists in marketing but not general managers who can run the business? Where was its leadership bench?

Succession 8

Succession Telecommunications Biotechnology Real Estate 8

Harvard Business Review

MARCH 8, 2013

Even development banks in emerging economies, like China and Brazil, are doing more than Silicon Valley-type "entrepreneurs.". government is often portrayed as providing a safeguard against market failure. The latter are the ones funding the capital-intensive and highest-risk projects. In a business context, the U.S.

Venture Capitalist 8

Venture Capitalist Biotechnology Fashion Innovation 8

Harvard Business Review

JUNE 16, 2016

To understand the nature of the problem, let’s look at how penicillin was brought to market. The Joint Center For Energy Storage Research (JCESR) has a five-year mandate to develop next generation battery technologies. The Valley of Death. Killing Ideas Faster.

Technology 8

Technology Venture Capitalist Supply Chain Innovation 8

Harvard Business Review

OCTOBER 22, 2013

In order to do this, your company needs a process to source radical ideas that can catapult your business to new heights, open up new markets, or bring in completely unfamiliar profit streams. Develop Creative Discontent. But in today’s ever-connected world, finding radical ideas seems to be getting tougher for companies.

Skills 8

Skills Power Six Sigma Disruptive Innovation 8

Harvard Business Review

OCTOBER 23, 2014

Used to its full potential, this is predictive medicine — the ability to integrate and analyze known disease characteristics with a specific patient’s history and health status, and use the resulting insights to change outcomes and inform new directions for life sciences research and development. They’re also sharing risk.

Health Care 8

Health Care Pharmaceuticals Information Technology Supply Chain 8

Harvard Business Review

FEBRUARY 16, 2016

However, outside North America they tend to be more optimistic about emerging economies: 36% of directors in Asia, 24% of directors in Australia and New Zealand, and 23% of directors in Africa predict faster growth in emerging economies than in developed countries in the next three years.

Politics 8

Politics Telecommunications Policies Biotechnology 8

The Horizons Tracker

DECEMBER 30, 2019

Location has always been vital for startups, both in terms of providing ready access to human capital to help develop the startup’s proposition, but also to provide ready access to a local market to help develop momentum. This has prompted many of the fastest growing companies of our age to congregate in the same places.

Biotechnology 56

Biotechnology Human Capital Travel Entrepreneur 56

Harvard Business Review

FEBRUARY 19, 2015

Or pay a freelance consultant to do market research? Clark recommends listing the “concrete skills you need to develop in order to be successful at pursuing your passion full-time.” Seek out training opportunities to help you develop the skills you need for your project. Patch weak spots.

Project 8

Project Outsourcing Learning-by-Doing Commitment 8

Harvard Business Review

MARCH 17, 2014

An estimated 250 funds are actively raising capital in a market that the Global Impact Investing Network estimates at $25 billion. Under the broad umbrella of impact investments lie myriad sectors, asset types, and investment products, most of which still need to be developed and understood. sanitation, housing, mobile banking).

Development 8

Development Microfinance Biotechnology Exit Strategy 8

Harvard Business Review

FEBRUARY 3, 2015

By managing the three key properties of networks that either propel you forward or hold you back—breadth, connectivity, and dynamism—you can develop a stronger network and use it as an essential leadership tool. The result was that their ideas were not developed. Learn more about your market value. Start a blog.

How To 8

How To Diversity Letter Learning-by-Doing 8

Harvard Business Review

NOVEMBER 29, 2016

The emergence of big data, as well as advancements in data science approaches and technology, is providing pharmaceutical companies with an opportunity to gain novel insights that can enhance and accelerate drug development. This information will ultimately support critical drug development decisions.

Pharmaceuticals 8

Pharmaceuticals Incubator Health Care Biotechnology 8

Harvard Business Review

MARCH 5, 2012

Thus, the decline of manufacturing is not completely a result of "natural" market forces. Indian companies, for instance, are already doing quite well exporting services like software development, technical support, and back-office processing to America. But let's not kid ourselves. Strengthening the industrial base.

Health Care 9

Health Care Biotechnology Industry Policies 9

Harvard Business Review

SEPTEMBER 11, 2014

That means new technologies and new competitors are hitting the market at an unprecedented rate. Companies that excel at resolving technological uncertainty often develop a broader technology palette. To illustrate this, consider that patent applications in the U.S. Consider the 2×2 matrix below.

Uncertainty 22

Uncertainty Industry Bottom-up Technology 22

Harvard Business Review

JUNE 12, 2012

trillion in government support for seven "strategic emerging industries," including alternative energy, biotechnology, next-gen IT, high-end manufacturing equipment, and advanced materials. Many wealthy societies have low human-development scores (e.g., It pledges $1.5 The contrast between the U.N.'s

First-mover Advantage 8

First-mover Advantage GDP Technology Biotechnology 8

Harvard Business Review

NOVEMBER 9, 2016

However, I fear that Mexico continuing its existing trade-based economic strategy will not necessarily produce different results in the long term — as it wouldn’t for any other developing country. For instance, breeding programs have developed cows to produce milk that is low in fat and high in omega-3 oils. When the U.S.

Cooper 14

Cooper Long-term Industry Health Care 14